Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
2(50.0%)
Phase 4
1(25.0%)
N/A
1(25.0%)
4Total
Phase 3(2)
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02323399Phase 4Recruiting

Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV

Role: lead

NCT03535870Not ApplicableCompleted

Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)

Role: lead

NCT03429400Phase 3Completed

Study of Oral Morphine Sulfate Administration in Pediatric Subjects

Role: lead

NCT01284556Phase 3Completed

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Role: lead

All 4 trials loaded